Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 03 06 2021
revised: 02 08 2021
accepted: 30 08 2021
pubmed: 7 9 2021
medline: 21 10 2021
entrez: 6 9 2021
Statut: ppublish

Résumé

South Asians, and Indians in particular, are known to have a higher incidence of premature atherosclerosis and acute coronary syndromes (ACS) with worse clinical outcomes, compared to populations with different ethnic backgrounds. However, the underlying pathobiology accounting for these differences has not been fully elucidated. ACS patients who had culprit lesion optical coherence tomography (OCT) imaging were enrolled. Culprit plaque characteristics were evaluated using OCT. Among 1315 patients, 100 were South Asian, 1009 were East Asian, and 206 were White. South Asian patients were younger (South Asians vs. East Asians vs. Whites: 51.6 ± 13.4 vs. 65.4 ± 11.9 vs. 62.7 ± 11.7; p < 0.001) and more frequently presented with ST-segment elevation myocardial infarction (STEMI) (77.0% vs. 56.4% vs. 35.4%; p < 0.001). On OCT analysis after propensity group matching, plaque erosion was more frequent (57.0% vs. 38.0% vs. 50.0%; p = 0.003), the lipid index was significantly greater (2281.6 [1570.8-3160.6] vs. 1624.3 [940.9-2352.4] vs. 1303.8 [1090.0-1757.7]; p < 0.001), and the prevalence of layered plaque was significantly higher in the South Asian group than in the other two groups (52.0% vs. 30.0% vs. 34.0%; p = 0.003). Compared to East Asians and Whites, South Asians with ACS were younger and more frequently presented with STEMI. Plaque erosion was the predominant pathology for ACS in South Asians and their culprit lesions had more features of plaque vulnerability. http://www.clinicaltrials.gov, NCT03479723.

Sections du résumé

BACKGROUND BACKGROUND
South Asians, and Indians in particular, are known to have a higher incidence of premature atherosclerosis and acute coronary syndromes (ACS) with worse clinical outcomes, compared to populations with different ethnic backgrounds. However, the underlying pathobiology accounting for these differences has not been fully elucidated.
METHODS METHODS
ACS patients who had culprit lesion optical coherence tomography (OCT) imaging were enrolled. Culprit plaque characteristics were evaluated using OCT.
RESULTS RESULTS
Among 1315 patients, 100 were South Asian, 1009 were East Asian, and 206 were White. South Asian patients were younger (South Asians vs. East Asians vs. Whites: 51.6 ± 13.4 vs. 65.4 ± 11.9 vs. 62.7 ± 11.7; p < 0.001) and more frequently presented with ST-segment elevation myocardial infarction (STEMI) (77.0% vs. 56.4% vs. 35.4%; p < 0.001). On OCT analysis after propensity group matching, plaque erosion was more frequent (57.0% vs. 38.0% vs. 50.0%; p = 0.003), the lipid index was significantly greater (2281.6 [1570.8-3160.6] vs. 1624.3 [940.9-2352.4] vs. 1303.8 [1090.0-1757.7]; p < 0.001), and the prevalence of layered plaque was significantly higher in the South Asian group than in the other two groups (52.0% vs. 30.0% vs. 34.0%; p = 0.003).
CONCLUSIONS CONCLUSIONS
Compared to East Asians and Whites, South Asians with ACS were younger and more frequently presented with STEMI. Plaque erosion was the predominant pathology for ACS in South Asians and their culprit lesions had more features of plaque vulnerability.
CLINICAL TRIAL REGISTRATION BACKGROUND
http://www.clinicaltrials.gov, NCT03479723.

Identifiants

pubmed: 34487786
pii: S0167-5273(21)01316-4
doi: 10.1016/j.ijcard.2021.08.048
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03479723']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-179

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Akihiro Nakajima (A)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Vijaykumar Subban (V)

Institute of Cardiovascular disease, Madras Medical Mission, Chennai, India.

Michele Russo (M)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Krzysztof L Bryniarski (KL)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Osamu Kurihara (O)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Makoto Araki (M)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Yoshiyasu Minami (Y)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Tsunenari Soeda (T)

Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Nara, Japan.

Taishi Yonetsu (T)

Department of Interventional Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Filippo Crea (F)

Department of Cardiovascular and Thoracic Science, Catholic University of the Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Roma, Italy.

Masamichi Takano (M)

Cardiovascular Center Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.

Takumi Higuma (T)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.

Tsunekazu Kakuta (T)

Department of Cardiology, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.

Tom Adriaenssens (T)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.

Niklas F Boeder (NF)

Department of Cardiology, University of Giessen, Giessen, Germany.

Holger M Nef (HM)

Department of Cardiology, University of Giessen, Giessen, Germany.

Owen C Raffel (OC)

Department of Cardiology, The Prince Charles Hospital, Brisbane, QLD, Australia.; Queensland University of Technology, Queensland, Australia; University of Queensland, Queensland, Australia.

Iris McNulty (I)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Hang Lee (H)

Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Sunao Nakamura (S)

Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan.

Jabir Abdullakutty (J)

Lisie Heart Institute, Lisie Hospital, Kochi, India.

Rony Mathew (R)

Lisie Heart Institute, Lisie Hospital, Kochi, India.

Mullasari Ajit Sankardas (MA)

Institute of Cardiovascular disease, Madras Medical Mission, Chennai, India.

Ik-Kyung Jang (IK)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Division of Cardiology, Kyung Hee University Hospital, Seoul, Republic of Korea. Electronic address: ijang@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH